# American States Water Co: financial statements, quarterly

AWR · NYSE · CIK 1056903 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/awr.md) · [Financials](/companies/awr/financials.md) · [Filings](/companies/awr/filings.md) · [Insiders](/companies/awr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/awr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [152](/filings/0001628280-24-045760.md) | [125 d](/filings/0001628280-26-009114.md) | [135](/filings/0001056903-25-000008.md) | [155](/filings/0001628280-25-038380.md) | [162](/filings/0001628280-25-049623.md) | [143 d](/filings/0001628280-26-009114.md) | [148](/filings/0001628280-26-031364.md) | [163](/filings/0001628280-26-053401.md) | [183](/filings/0001628280-25-049623.md) | [164 d](/filings/0001628280-26-009114.md) | [169](/filings/0001628280-26-031364.md) | [181](/filings/0001628280-26-053401.md) |
| Cost of revenue | $m | not reported | not reported | [15.7](/filings/0001056903-25-000008.md) | [16.2](/filings/0001628280-25-038380.md) | [11.8](/filings/0001628280-25-049623.md) | [10.9 d](/filings/0001628280-26-009114.md) | [12.9](/filings/0001628280-26-031364.md) | [12.9](/filings/0001628280-26-053401.md) | [16.5](/filings/0001628280-25-049623.md) | [18.3 d](/filings/0001628280-26-009114.md) | [17.3](/filings/0001628280-26-031364.md) | [16.7](/filings/0001628280-26-053401.md) |
| Operating income | $m | [51.8](/filings/0001628280-24-045760.md) | [34.9 d](/filings/0001628280-26-009114.md) | [39.0](/filings/0001056903-25-000008.md) | [51.7](/filings/0001628280-25-038380.md) | [55.1](/filings/0001628280-25-049623.md) | [38.7 d](/filings/0001628280-26-009114.md) | [45.5](/filings/0001628280-26-031364.md) | [51.0](/filings/0001628280-26-053401.md) | [61.7](/filings/0001628280-25-049623.md) | [45.0 d](/filings/0001628280-26-009114.md) | [51.4](/filings/0001628280-26-031364.md) | [64.0](/filings/0001628280-26-053401.md) |
| Interest expense | $m | [11.7](/filings/0001628280-23-037070.md) | [10.9 d](/filings/0001628280-24-005922.md) | [12.9](/filings/0001628280-24-021131.md) | [13.1](/filings/0001628280-24-035232.md) | [13.2](/filings/0001628280-25-049623.md) | [11.2 d](/filings/0001628280-26-009114.md) | [12.1](/filings/0001628280-26-031364.md) | [12.1](/filings/0001628280-26-053401.md) | [11.7](/filings/0001628280-25-049623.md) | [10.9 d](/filings/0001628280-26-009114.md) | [12.1](/filings/0001628280-26-031364.md) | [12.2](/filings/0001628280-26-053401.md) |
| Income tax | $m | [9.5](/filings/0001628280-24-045760.md) | [8.1 d](/filings/0001628280-26-009114.md) | [7.4](/filings/0001056903-25-000008.md) | [10.4](/filings/0001628280-25-038380.md) | [10.1](/filings/0001628280-25-049623.md) | [2.4 d](/filings/0001628280-26-009114.md) | [8.5](/filings/0001628280-26-031364.md) | [10.2](/filings/0001628280-26-053401.md) | [12.9](/filings/0001628280-25-049623.md) | [7.7 d](/filings/0001628280-26-009114.md) | [9.9](/filings/0001628280-26-031364.md) | [14.5](/filings/0001628280-26-053401.md) |
| Net income | $m | [31.6](/filings/0001628280-24-045760.md) | [20.4 d](/filings/0001628280-26-009114.md) | [23.1](/filings/0001628280-25-049623.md) | [31.9](/filings/0001628280-25-049623.md) | [35.8](/filings/0001628280-25-049623.md) | [28.4 d](/filings/0001628280-26-009114.md) | [26.8](/filings/0001628280-26-053401.md) | [33.7](/filings/0001628280-26-053401.md) | [41.2](/filings/0001628280-25-049623.md) | [28.7 d](/filings/0001628280-26-009114.md) | [29.9](/filings/0001628280-26-053401.md) | [43.3](/filings/0001628280-26-053401.md) |
| Diluted EPS | $ per share | [0.85](/filings/0001628280-24-045760.md) | not reported | [0.62](/filings/0001056903-25-000008.md) | [0.85](/filings/0001628280-25-038380.md) | [0.95](/filings/0001628280-25-049623.md) | not reported | [0.70](/filings/0001628280-26-031364.md) | [0.87](/filings/0001628280-26-053401.md) | [1.06](/filings/0001628280-25-049623.md) | not reported | [0.76](/filings/0001628280-26-031364.md) | [1.09](/filings/0001628280-26-053401.md) |
| Basic EPS | $ per share | [0.85](/filings/0001628280-24-045760.md) | not reported | [0.62](/filings/0001056903-25-000008.md) | [0.85](/filings/0001628280-25-038380.md) | [0.95](/filings/0001628280-25-049623.md) | not reported | [0.70](/filings/0001628280-26-031364.md) | [0.87](/filings/0001628280-26-053401.md) | [1.06](/filings/0001628280-25-049623.md) | not reported | [0.76](/filings/0001628280-26-031364.md) | [1.10](/filings/0001628280-26-053401.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.6](/filings/0001628280-23-037070.md) | [14.1](/filings/0001628280-25-006389.md) | [17.0](/filings/0001628280-24-021131.md) | [3.6](/filings/0001628280-24-035232.md) | [16.5](/filings/0001628280-24-045760.md) | [26.7](/filings/0001628280-26-009114.md) | [21.2](/filings/0001056903-25-000008.md) | [20.2](/filings/0001628280-25-038380.md) | [26.1](/filings/0001628280-25-049623.md) | [18.8](/filings/0001628280-26-053401.md) | [22.2](/filings/0001628280-26-031364.md) | [21.7](/filings/0001628280-26-053401.md) |
| Current assets | $m | [192](/filings/0001628280-23-037070.md) | [206](/filings/0001628280-25-006389.md) | [205](/filings/0001628280-24-021131.md) | [210](/filings/0001628280-24-035232.md) | [222](/filings/0001628280-24-045760.md) | [233](/filings/0001628280-26-009114.md) | [238](/filings/0001056903-25-000008.md) | [252](/filings/0001628280-25-038380.md) | [251](/filings/0001628280-25-049623.md) | [231](/filings/0001628280-26-053401.md) | [221](/filings/0001628280-26-031364.md) | [226](/filings/0001628280-26-053401.md) |
| Total assets | $m | [2,205](/filings/0001628280-24-045760.md) | [2,246](/filings/0001628280-25-006389.md) | [2,293](/filings/0001628280-24-021131.md) | [2,348](/filings/0001628280-24-035232.md) | [2,421](/filings/0001628280-24-045760.md) | [2,500](/filings/0001628280-26-009114.md) | [2,545](/filings/0001056903-25-000008.md) | [2,611](/filings/0001628280-25-038380.md) | [2,655](/filings/0001628280-25-049623.md) | [2,715](/filings/0001628280-26-053401.md) | [2,734](/filings/0001628280-26-031364.md) | [2,775](/filings/0001628280-26-053401.md) |
| Current liabilities | $m | [195](/filings/0001628280-23-037070.md) | [167](/filings/0001628280-25-006389.md) | [179](/filings/0001628280-24-021131.md) | [299](/filings/0001628280-24-035232.md) | [321](/filings/0001628280-24-045760.md) | [286](/filings/0001628280-26-009114.md) | [294](/filings/0001056903-25-000008.md) | [162](/filings/0001628280-25-038380.md) | [197](/filings/0001628280-25-049623.md) | [175](/filings/0001628280-26-053401.md) | [182](/filings/0001628280-26-031364.md) | [231](/filings/0001628280-26-053401.md) |
| Long-term debt | $m | [575](/filings/0001628280-23-037070.md) | [576](/filings/0001628280-25-006389.md) | [576](/filings/0001628280-24-021131.md) | [640](/filings/0001628280-24-035232.md) | [640](/filings/0001628280-24-045760.md) | [640](/filings/0001628280-26-009114.md) | [690](/filings/0001056903-25-000008.md) | [789](/filings/0001628280-25-038380.md) | [790](/filings/0001628280-25-049623.md) | [783](/filings/0001628280-26-053401.md) | [783](/filings/0001628280-26-031364.md) | [718](/filings/0001628280-26-053401.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [771](/filings/0001628280-24-045760.md) | [776](/filings/0001628280-26-009114.md) | [800](/filings/0001628280-25-049623.md) | [833](/filings/0001628280-25-049623.md) | [879](/filings/0001628280-25-049623.md) | [920](/filings/0001628280-26-053401.md) | [956](/filings/0001628280-26-053401.md) | [973](/filings/0001628280-26-053401.md) | [1,009](/filings/0001628280-25-049623.md) | [1,046](/filings/0001628280-26-053401.md) | [1,064](/filings/0001628280-26-053401.md) | [1,121](/filings/0001628280-26-053401.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.8 d](/filings/0001628280-24-045760.md) | [11.2 d](/filings/0001628280-26-009114.md) | [45.8](/filings/0001056903-25-000008.md) | [24.7 d](/filings/0001628280-25-038380.md) | [63.7 d](/filings/0001628280-25-049623.md) | [64.5 d](/filings/0001628280-26-009114.md) | [45.1](/filings/0001628280-26-031364.md) | [64.6 d](/filings/0001628280-26-053401.md) | [92.4 d](/filings/0001628280-25-049623.md) | [27.7 d](/filings/0001628280-26-009114.md) | [71.6](/filings/0001628280-26-031364.md) | [44.9 d](/filings/0001628280-26-053401.md) |
| Capital expenditure | $m | [47.5 d](/filings/0001628280-24-045760.md) | [52.4 d](/filings/0001628280-26-009114.md) | [47.6](/filings/0001056903-25-000008.md) | [61.7 d](/filings/0001628280-25-038380.md) | [64.2 d](/filings/0001628280-25-049623.md) | [58.5 d](/filings/0001628280-26-009114.md) | [67.6](/filings/0001628280-26-031364.md) | [50.9 d](/filings/0001628280-26-053401.md) | [54.6 d](/filings/0001628280-25-049623.md) | [63.7 d](/filings/0001628280-26-009114.md) | [49.1](/filings/0001628280-26-031364.md) | [48.5 d](/filings/0001628280-26-053401.md) |
| Dividends paid | $m | [15.9 d](/filings/0001628280-24-045760.md) | [15.9 d](/filings/0001628280-26-009114.md) | [15.9](/filings/0001056903-25-000008.md) | [16.0 d](/filings/0001628280-25-038380.md) | [17.5 d](/filings/0001628280-25-049623.md) | [17.6 d](/filings/0001628280-26-009114.md) | [17.8](/filings/0001628280-26-031364.md) | [17.9 d](/filings/0001628280-26-053401.md) | [19.4 d](/filings/0001628280-25-049623.md) | [19.6 d](/filings/0001628280-26-009114.md) | [19.7](/filings/0001628280-26-031364.md) | [19.8 d](/filings/0001628280-26-053401.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.0](/filings/0001628280-23-037070.md) | [37.0](/filings/0001628280-24-021131.md) | [37.1](/filings/0001628280-24-035232.md) | [37.1](/filings/0001628280-24-045760.md) | [37.1](/filings/0001056903-25-000008.md) | [37.4](/filings/0001628280-25-038380.md) | [37.7](/filings/0001628280-25-049623.md) | [38.4](/filings/0001628280-26-031364.md) | [38.6](/filings/0001628280-26-053401.md) | [38.7](/filings/0001628280-25-049623.md) | [39.2](/filings/0001628280-26-031364.md) | [39.5](/filings/0001628280-26-053401.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,635,626 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053401.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.